He received his Ph.D. in biochemistry from Yonsei University, Korea and Post-Doc program in Mayo Clinic, USA.
Dr. Hoil Choi leads Peptron, which brings a robust superiority in drug delivery system industry and demonstrating notable achievements in therapeutic areas such as neurodegenerative diseases, cancer, acromegaly, and metabolic diseases. He found Petron Inc. in 1997 and has over 25 years of experience about peptide research. He began his career with Korea Research Institute of Bioscience & Biotechnology (KRIBB) as a research scientist in 1990. He moved to LG Chemical Co. Ltd where he developed synthesis method and many peptides.
Honors & Awards